selected publications

• article

  • Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: Comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension study.  Annals of the Rheumatic Diseases.  76:355-363. 2017-01-01
  • Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study.  Annals of the Rheumatic Diseases.  76:346-354. 2017-01-01